查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2014979

醫藥物流市場：按類型、產品類型、組件、運輸方式和最終用戶分類－2026-2032年全球市場預測

Pharmaceutical Logistics Market by Type, Product, Component, Mode Of Transport, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年醫藥物流市場價值為900.6億美元，預計到2026年將成長至966.7億美元，複合年成長率為8.97%，到2032年將達到1644億美元。

主要市場統計數據
基準年 2025 900.6億美元
預計年份：2026年 966.7億美元
預測年份 2032 1644億美元
複合年成長率 (%) 8.97%

權威的藥品物流指南，揭示了建立具有韌性的供應鏈所面臨的營運壓力、合規要求和投資重點。

醫藥物流產業在臨床緊迫性、監管嚴格性和全球貿易複雜性的交織下運作。近年來，醫藥供應鏈面臨間歇性中斷、不斷變化的溫控要求以及監管機構和支付方日益嚴格的審查等挑戰。因此，物流相關人員平衡各種相互衝突的需求：既要透過確保產品完整性來保障病人安全，也要同時在高度受限的營運環境中最佳化成本和前置作業時間。

技術進步、產品複雜性增加以及策略整合如何迅速將醫藥物流轉變為值得信賴的、數據主導的服務經濟。

在技​​術成熟、產品特性不斷演變以及監管要求日益提高的推動下，醫藥物流格局正經歷著一場變革。複雜生物製藥和個人化療法的出現，促使人們對貫穿整個分銷生命週期的精準溫控和序列化追蹤的需求不斷成長，加速了低溫運輸的專業化和先進監控解決方案的普及應用。同時，能夠實現即時視覺化和預測分析的數位化平台，正將價值創造的重心從單純的運輸能力轉移到服務品質和可靠性。

2025 年美國關稅政策對全球供應鏈中藥品運輸路線、供應商選擇和貿易合規策略的實際影響。

2025年美國關稅環境將對醫藥物流決策產生複雜影響，迫使企業重新評估全球供應鏈的運輸路線、採購方式和成本分配。關稅政策的變化迫使相關人員重新評估供應商和承運商的選擇，以降低到貨成本波動並維持供應的連續性。對許多生命科學公司而言，目前的因應措施主要集中在戰術性：具體而言，包括改變運輸路線以避開高關稅地區、增加對保稅倉庫的依賴，以及盡可能加快在地採購，以降低對關稅敏感的物流環節的影響。

可操作的細分情報，區分低溫運輸和非低溫運輸需求、組件功能、產品複雜性、運輸方式、細分應用和最終用戶期望。

對市場區隔進行詳細分析後發現，不同的需求和服務期望應指南策略投資。就物流類型而言，低溫運輸物流需要端到端的溫度控制、嚴格的保溫包裝認證以及​​支援監管可追溯性的監控技術。而非低溫運輸物流則更注重貨量、運輸效率和成本最佳化的倉儲策略。這兩種物流類型之間的轉換需要清晰的營運規程和資金配置決策。

從區域觀點看美洲、歐洲、中東和非洲以及亞太地區的醫藥物流基礎設施、監管細微差別和營運重點。

區域趨勢影響物流供應商和製藥公司的營運重點和投資決策。在美洲，重點在於分銷規模和最後一公里最佳化，特別關注北美地區的跨境物流流動以及拉丁美洲市場基礎設施​​的多樣性。應對這些挑戰需要高度靈活的運輸策略、完善的清關流程以及能夠確保跨區域低溫運輸穩定運作的夥伴關係。

決定醫藥分銷領域物流供應商和技術供應商成功的關鍵競爭差異化因素和夥伴關係策略。

物流和服務供應商之間的競爭格局正趨於幾個關鍵差異化因素：成熟的低溫運輸專業知識、數位化視覺性和分析能力、合規性和品管，以及覆蓋範圍廣且具備專業優勢的細分市場。領先的供應商正在投資建造檢驗的倉儲設施、整合監控系統以及能夠支援對溫度敏感的生物製藥和大批量藥品分銷的服務組合。透過這些舉措，他們正從單純的承運商轉型為承擔端到端責任的整合供應鏈合作夥伴。

為產業領導者提供切實可行的多面向藍圖，以推動營運課責，同時加強低溫運輸韌性、貿易彈性和策略夥伴關係。

產業領導者必須採取綜合策略，兼顧短期韌性與長期轉型。首先，投資建設分層式低溫運輸基礎設施，使設施認證和溫度控制技術與產品風險等級相符。這種方法能夠將高成本的資源有效率地分配給對溫度最敏感的SKU，同時保持柔軟性，滿足各種不同的配送需求。為了配合實體投資，還應實施先進的監控和分析技術，從被動的事件管理轉向預測性維護和路線最佳化。

透過基於從業者觀點的高度透明的調查方法，我們將對高階主管的初步訪談與輔助性二手資訊結合，從而得出有關物流的實用見解。

本分析整合了第一手和第二手調查數據，旨在對醫藥物流趨勢進行嚴謹且可重複的評估。第一手調查包括對製造和醫療機構的高級物流主管、低溫運輸專家、法規遵循官員和採購負責人進行結構化訪談。訪談內容聚焦於營運重點、能力差距、技術應用以及對貿易和政策變化的因應觀點，從而提供切實可行的建議。

結論闡述了為什麼對低溫運輸能力、數位化可視性和管治的策略性投資正在決定醫藥供應鏈的領導地位。

高效率的醫藥物流不再只是後勤部門職能，而是提升競爭力的關鍵驅動力，隨著產品複雜性和監管要求的提高，其重要性只會與日俱增。那些將物流視為戰略能力，並將對檢驗的低溫運輸基礎設施、先進的監測分析技術以及貿易和政策適應能力的投資納入其計劃的企業，將更有能力確保產品完整性，滿足患者需求，並有效控制服務總成本。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 醫藥物流市場：依類型分類

  • 低溫運輸物流
  • 非低溫運輸物流

第9章 醫藥物流市場：依產品分類

  • 生物製藥
    • 單株抗體
    • 胜肽
    • 蛋白質
  • 品牌藥品
  • 學名藥
    • 非處方藥（OTC）
    • 處方箋學名藥

第10章 醫藥物流市場：依組成部分分類

  • 分配
  • 監測
  • 包裝
  • 倉儲管理

第11章 以運輸方式分類的醫藥物流市場

  • 空運貨物
    • 包機
    • 普通貨物
  • 陸路交通
    • 鐵路
    • 卡車運輸
  • 海上運輸
    • 貨櫃運輸
    • 滾裝船

第12章 醫藥物流市場：依最終用戶分類

  • 醫療保健提供者
  • 製藥生產
  • 研究機構

第13章 醫藥物流市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫藥物流市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 醫藥物流市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國醫學流市場

第17章：中國醫藥藥物流市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AP Moller-Maersk A/S
  • Air Canada
  • AIT Worldwide Logistics, Inc.
  • Almac Group
  • AWL India Private Limited
  • Bilcare Limited
  • CH Robinson Worldwide, Inc.
  • Catalent, Inc.
  • Cencora Inc.
  • CEVA Logistics
  • Clinigen Group PLC
  • Crown LSP Group
  • DHL International GmbH by Deutsche Post AG
  • DSV A/S
  • FedEx Corporation
  • ICON PLC
  • Infosys Limited
  • Kerry Logistics Network Limited
  • Kuehne+Nagel International AG
  • Lineage, Inc.
  • Lonza Group Ltd.
  • Movianto Group
  • NextPharma Logistics GmbH
  • Nippon Express Co., Ltd.
  • Parexel International Corporation
  • SEKO Logistics
  • SF Express Co., Ltd.
  • Thermo Fisher Scientific, Inc.
  • United Parcel Service of America, Inc.
  • YUSEN LOGISTICS CO., LTD.
Product Code: MRR-437E8FA7421A

The Pharmaceutical Logistics Market was valued at USD 90.06 billion in 2025 and is projected to grow to USD 96.67 billion in 2026, with a CAGR of 8.97%, reaching USD 164.40 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 90.06 billion
Estimated Year [2026] USD 96.67 billion
Forecast Year [2032] USD 164.40 billion
CAGR (%) 8.97%

An authoritative orientation to pharmaceutical logistics that clarifies operational pressures, compliance imperatives, and investment priorities shaping resilient supply chains

The pharmaceutical logistics sector operates at the confluence of clinical urgency, regulatory rigor, and global trade complexity. In recent years, supply chains for pharmaceuticals have been tested by episodic disruptions, evolving temperature-control demands, and heightened scrutiny from regulators and payors. Consequently, logistics stakeholders must balance competing imperatives: ensuring patient safety through uncompromising product integrity while simultaneously optimizing cost and lead times in a constrained operating environment.

This report presents an integrated vantage that synthesizes operational realities, technology adoption trends, and policy dynamics affecting logistics providers, manufacturers, and institutional buyers. It frames critical vulnerabilities and strengths within distribution networks and underscores the role of collaborative partnerships in maintaining continuity. By assessing the interplay between infrastructure capabilities, service design, and compliance obligations, the analysis helps leaders prioritize investments that reduce risk and increase responsiveness.

Throughout the review, emphasis is placed on the practical implications of emerging practices such as advanced temperature monitoring, end-to-end visibility platforms, and modular warehousing strategies. These elements are examined not only for their technological sophistication but also for their operational feasibility, cost-to-implement considerations, and alignment with stakeholder expectations across clinical, commercial, and regulatory functions.

How technological advances, product complexity, and strategic consolidation are rapidly reshaping pharmaceutical logistics into a reliability- and data-driven service economy

The landscape of pharmaceutical logistics is undergoing transformative shifts driven by technological maturation, changing product profiles, and intensified regulatory expectations. Complex biologic products and personalized therapies have increased demand for precise temperature controls and serialized tracking throughout the distribution lifecycle, which in turn accelerates adoption of cold chain specialization and advanced monitoring solutions. Simultaneously, digital platforms enabling real-time visibility and predictive analytics are shifting value capture from capacity alone toward service quality and reliability.

In parallel, the industry is witnessing consolidation among third-party logistics providers and strategic alliances between carriers and life sciences companies, which reconfigure network design and service offerings. These structural changes are reinforced by investments in flexible storage and packaging systems that support multi-temperature SKUs and rapid fulfillment for time-sensitive deliveries. Moreover, environmental sustainability considerations are prompting experimentation with reusable packaging and energy-efficient cold storage, adding another layer of decision criteria for operators.

Taken together, these developments demand a reorientation of capabilities. Providers that integrate robust monitoring, adaptable storage, and agile transport orchestration position themselves to meet evolving product complexity and heightened customer expectations. At the same time, manufacturers and institutional buyers are recalibrating supplier selection criteria to emphasize reliability, data transparency, and proven cold chain expertise, creating a new competitive dynamic in logistics procurement.

Practical implications of the 2025 United States tariff policy on pharmaceutical routing, supplier selection, and trade-compliance strategies across global supply chains

The United States tariff environment in 2025 has created a complex overlay on pharmaceutical logistics decisions, reshaping routing, sourcing, and cost allocation across global supply chains. Tariff policy changes have prompted stakeholders to reassess supplier and carrier selection in order to mitigate landed-cost volatility and maintain supply continuity. For many life sciences organizations, the immediate response has been tactical: rerouting shipments to avoid high-duty corridors, increasing reliance on bonded warehousing, and accelerating localization where feasible to reduce exposure to tariff-sensitive flows.

Beyond those immediate adjustments, the tariff landscape is also catalyzing strategic shifts. Firms are reassessing regional network design to diversify inbound flows across ports and transport modes, and are renegotiating commercial terms with logistics partners to share or hedge tariff risk. In addition, companies are placing greater emphasis on documentation integrity and customs compliance capabilities to minimize costly delays and penalties that can compound the financial impact of duties. These changes have secondary effects on inventory policy, with some organizations opting to increase safety stock in proximate distribution centers to offset potential border disruptions.

Ultimately, the tariff-driven reconfiguration highlights the importance of agility and scenario planning in logistics strategy. Organizations that proactively incorporate trade-policy sensitivity into routing algorithms, supplier contracts, and inventory positioning will be better equipped to preserve service levels while managing cost exposure in an uncertain trade environment.

Actionable segmentation intelligence that differentiates cold chain and non-cold chain needs, component capabilities, product complexity, transport modes, application niches, and end-user expectations

A granular view of segmentation reveals differentiated needs and service expectations that should guide strategic investments. When considering logistical type, cold chain logistics demands end-to-end temperature integrity, rigorous qualification of insulated packaging, and monitoring technologies that support regulatory traceability, whereas non-cold chain logistics emphasizes volume handling, transit efficiency, and cost-optimized storage strategies. Transitioning between these types requires distinct operational protocols and capital allocation decisions.

Component-level segmentation further clarifies capability gaps and procurement priorities. Distribution operations call for flexible transportation modes and reliable carrier networks; monitoring necessitates investment in sensors, data platforms, and analytics to evidence compliance; packaging solutions must balance thermal performance with material sustainability; and storage and warehousing require facility qualification, validated temperature zones, and trained personnel to manage sensitive inventory.

Product-driven segmentation underpins service differentiation. Biologic products, including monoclonal antibodies, peptides, and proteins, typically require stringent cold chain controls and traceable handling, while branded drugs often combine temperature requirements with commercial distribution rules. Generic pharmaceuticals split into over-the-counter and prescription generics, each presenting different demand patterns and packaging resilience, which influence choices in transport frequency, containerization, and inventory tactics.

Mode of transport segmentation influences speed, cost, and risk profiles. Air freight, whether via charter services or commercial cargo, prioritizes speed and minimal dwell time; road transportation-across rail and trucking-offers cost-efficient regional connectivity and flexibility for last-mile delivery; and sea freight through container shipping or roll-on/roll-off presents economies for bulk international movements but introduces longer lead times and greater exposure to temperature excursions.

Application-based segmentation highlights sector-specific workflows. Bio pharma requires stringent compliance protocols and often cold chain specialization, chemical pharma demands hazardous-material handling expertise and controlled environments, and specialized pharma may combine unique handling, security, and documentation needs. Finally, end-user segmentation into healthcare providers, pharmaceutical manufacturing, and research institutions shapes service level agreements, delivery cadence, and value-added services such as direct-to-clinic fulfillment or clinical trial kit management.

A region-by-region perspective on infrastructure, regulatory nuance, and operational priorities shaping pharmaceutical logistics in the Americas, EMEA, and Asia-Pacific

Regional dynamics shape operational priorities and investment decisions for logistics providers and pharmaceutical companies. In the Americas, emphasis is placed on distribution scale and last-mile optimization, with particular attention to cross-border flows in North America and to infrastructure variability across Latin American markets. These conditions require adaptable transport strategies, enhanced customs proficiency, and partnerships that can deliver consistent cold chain performance across diverse geographies.

In Europe, Middle East & Africa, regulatory harmonization in parts of Europe intersects with fragmented infrastructure in other areas, creating a mosaic of compliance and operational requirements. Providers must balance centralized distribution models that leverage advanced hub capabilities with localized solutions that handle last-mile complexity and country-specific regulations. The region also presents opportunities to deploy energy-efficient cold storage solutions and integrated visibility platforms to manage cross-border cold chain integrity.

Asia-Pacific continues to be characterized by rapidly evolving manufacturing footprints, urbanization-driven last-mile challenges, and a broad spectrum of infrastructure maturity. Many markets within the region are scaling up biologics manufacturing capacity and demand sophisticated cold chain capabilities, prompting investments in qualified warehousing and multimodal transport options. Across regions, stakeholders increasingly prioritize partnerships that combine local market expertise with global standards to manage compliance, security, and service reliability.

Key competitive differentiators and partnership strategies that are defining success among logistics providers and technology suppliers in pharmaceutical distribution

Competitive dynamics among logistics and service providers are converging on a few decisive differentiators: proven cold chain expertise, digital visibility and analytics, compliance and quality management, and geographic reach combined with niche specialization. Leading providers are investing in validated storage facilities, integrated monitoring systems, and service portfolios that support temperature-sensitive biologics alongside high-volume pharmaceutical distribution. In doing so, they are repositioning from pure-transport businesses toward integrated supply chain partners that offer end-to-end accountability.

Strategic partnerships and acquisitions are being used to accelerate capability development, especially where rapid entry into specialized cold chain services or regional markets is required. Technology vendors that supply monitoring hardware and software platforms are increasingly collaborating with logistics providers to embed continuous temperature sensing, automated alerts, and data analytics into routine operations. This integration enhances compliance documentation, reduces manual processes, and supports performance-based commercial models.

From a buyer perspective, supplier selection criteria have shifted to emphasize transparency, incident response capability, and auditable processes. Organizations are also evaluating providers on their ability to support circular packaging initiatives and sustainability commitments without compromising cold chain integrity. As a result, providers that can demonstrate measurable improvements in service reliability, robust quality systems, and a clear roadmap for innovation are most likely to capture strategic engagements.

A pragmatic, multi-dimensional roadmap for industry leaders to strengthen cold chain resilience, trade agility, and strategic partnerships while driving operational accountability

Industry leaders must adopt an integrated agenda that balances immediate resilience with longer-term transformation. First, invest in tiered cold chain infrastructure that aligns facility qualification and temperature-control technology to product risk profiles. This approach enables efficient allocation of high-cost resources to the most temperature-sensitive SKUs while preserving flexibility for broader distribution needs. Complementary to physical investments, deploy advanced monitoring and analytics to move from reactive incident management toward predictive maintenance and route optimization.

Second, embed trade-policy and customs expertise into supply chain planning to mitigate tariff and regulatory volatility. Scenario-based modeling and dynamic routing protocols can reduce exposure to sudden policy shifts, while stronger contractual terms with carriers can share risk in high-exposure corridors. Third, prioritize partnerships with specialized providers and technology vendors to accelerate capability expansion; strategic alliances can deliver validated cold storage, last-mile expertise, and integrated data platforms without requiring full in-house development.

Finally, build governance and performance frameworks that align procurement, quality, and operations. Instituting clear service-level agreements, incident response playbooks, and continuous improvement cycles ensures accountability and drives measurable reliability gains. By pursuing this multi-pronged strategy, leaders can reduce service disruption risk, control costs pragmatically, and strengthen their ability to support increasingly complex pharmaceutical product portfolios.

A transparent, practitioner-focused research methodology integrating primary leadership interviews and corroborating secondary sources to produce actionable logistics insights

This analysis synthesizes primary and secondary research to produce a rigorous, reproducible assessment of pharmaceutical logistics dynamics. Primary research included structured interviews with senior logistics executives, cold chain specialists, regulatory compliance leads, and procurement professionals across manufacturing and healthcare organizations. These conversations focused on operational priorities, capability gaps, technology adoption, and responses to trade and policy shifts, providing frontline perspectives that inform practical recommendations.

Secondary research comprised a review of publicly available regulatory guidance, industry white papers, technology provider specification documents, and case studies from leading logistics implementations. Triangulation of primary insights with secondary evidence allowed for validation of emergent themes such as the increased focus on biologics cold chain, the centrality of digital visibility, and the operational consequences of tariff shifts. Methodological rigor was maintained through cross-validation among interviewees, iterative synthesis of common patterns, and attention to regional differentiators that affect feasibility and prioritization.

Limitations are acknowledged: the analysis focuses on structural and operational trends rather than quantitative market sizing, and while it accounts for a broad set of geographies and stakeholder types, some micro-market nuances may require localized validation. Nonetheless, the methodology emphasizes applicability, ensuring that findings support actionable decisions for procurement, operations, and strategic planning.

Concluding perspective on why strategic investment in cold chain capabilities, digital visibility, and governance will determine pharmaceutical supply chain leadership

Effective pharmaceutical logistics is now a competitive enabler rather than a back-office function, and its importance will only increase as product complexity and regulatory expectations rise. Organizations that treat logistics as a strategic capability-investing in validated cold chain infrastructure, integrating advanced monitoring and analytics, and embedding trade-policy resilience into planning-will be better positioned to ensure product integrity, meet patient needs, and manage total cost to serve.

Moreover, the convergence of technology and specialized service models creates an opportunity to shift provider relationships from transactional to strategic partnerships. By prioritizing transparency, data-driven decision-making, and continuous improvement, stakeholders can reduce supply disruptions and create operational agility. As the industry adapts to tariff dynamics, evolving product profiles, and regional infrastructure variances, the capacity to translate insight into nimble execution will distinguish leaders from laggards.

In closing, the imperative is clear: align investments to product risk, leverage partnerships to accelerate capability, and institutionalize governance that converts operational improvements into reliable, auditable performance. Doing so will enable sustainable, resilient pharmaceutical logistics that uphold patient safety and commercial continuity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Logistics Market, by Type

  • 8.1. Cold Chain Logistics
  • 8.2. Non-Cold Chain Logistics

9. Pharmaceutical Logistics Market, by Product

  • 9.1. Biologic Products
    • 9.1.1. Monoclonal Antibodies
    • 9.1.2. Peptides
    • 9.1.3. Proteins
  • 9.2. Branded Drugs
  • 9.3. Generic Pharmaceuticals
    • 9.3.1. Over-The-Counter (OTC)
    • 9.3.2. Prescription Generics

10. Pharmaceutical Logistics Market, by Component

  • 10.1. Distribution
  • 10.2. Monitoring
  • 10.3. Packaging
  • 10.4. Storage & Warehousing

11. Pharmaceutical Logistics Market, by Mode Of Transport

  • 11.1. Air Freight
    • 11.1.1. Charter Services
    • 11.1.2. Commercial Cargo
  • 11.2. Road Transportation
    • 11.2.1. Rail
    • 11.2.2. Trucking
  • 11.3. Sea Freight
    • 11.3.1. Container Shipping
    • 11.3.2. Roll-On/Roll-Off

12. Pharmaceutical Logistics Market, by End User

  • 12.1. Healthcare Providers
  • 12.2. Pharmaceutical Manufacturing
  • 12.3. Research Institutions

13. Pharmaceutical Logistics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pharmaceutical Logistics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pharmaceutical Logistics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Pharmaceutical Logistics Market

17. China Pharmaceutical Logistics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. A.P. Moller - Maersk A/S
  • 18.6. Air Canada
  • 18.7. AIT Worldwide Logistics, Inc.
  • 18.8. Almac Group
  • 18.9. AWL India Private Limited
  • 18.10. Bilcare Limited
  • 18.11. C.H. Robinson Worldwide, Inc.
  • 18.12. Catalent, Inc.
  • 18.13. Cencora Inc.
  • 18.14. CEVA Logistics
  • 18.15. Clinigen Group PLC
  • 18.16. Crown LSP Group
  • 18.17. DHL International GmbH by Deutsche Post AG
  • 18.18. DSV A/S
  • 18.19. FedEx Corporation
  • 18.20. ICON PLC
  • 18.21. Infosys Limited
  • 18.22. Kerry Logistics Network Limited
  • 18.23. Kuehne + Nagel International AG
  • 18.24. Lineage, Inc.
  • 18.25. Lonza Group Ltd.
  • 18.26. Movianto Group
  • 18.27. NextPharma Logistics GmbH
  • 18.28. Nippon Express Co., Ltd.
  • 18.29. Parexel International Corporation
  • 18.30. SEKO Logistics
  • 18.31. SF Express Co., Ltd.
  • 18.32. Thermo Fisher Scientific, Inc.
  • 18.33. United Parcel Service of America, Inc.
  • 18.34. YUSEN LOGISTICS CO., LTD.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD CHAIN LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD CHAIN LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD CHAIN LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON-COLD CHAIN LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON-COLD CHAIN LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON-COLD CHAIN LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PEPTIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PEPTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PROTEINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION GENERICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION GENERICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION GENERICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DISTRIBUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DISTRIBUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DISTRIBUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE & WAREHOUSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE & WAREHOUSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE & WAREHOUSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHARTER SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHARTER SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHARTER SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMMERCIAL CARGO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMMERCIAL CARGO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMMERCIAL CARGO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRUCKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRUCKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRUCKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTAINER SHIPPING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTAINER SHIPPING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTAINER SHIPPING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROLL-ON/ROLL-OFF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROLL-ON/ROLL-OFF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROLL-ON/ROLL-OFF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 194. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 196. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 197. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 198. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 199. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 200. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 201. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 227. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 228. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 229. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 230. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 231. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 232. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 233. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 234. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 238. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 239. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 240. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 241. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 242. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 243. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 244. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 245. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)